These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14561092)

  • 1. Synthesis and pharmacological evaluation of 1-oxo-2-(3-piperidyl)-1,2,3,4- tetrahydroisoquinolines and related analogues as a new class of specific bradycardic agents possessing I(f) channel inhibitory activity.
    Kubota H; Kakefuda A; Watanabe T; Ishii N; Wada K; Masuda N; Sakamoto S; Tsukamoto S
    J Med Chem; 2003 Oct; 46(22):4728-40. PubMed ID: 14561092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and pharmacological evaluation of 2-(3-piperidyl)-1,2,3,4-tetrahydroisoquinoline derivatives as specific bradycardic agents.
    Kakefuda A; Watanabe T; Taguchi Y; Masuda N; Tanaka A; Yanagisawa I
    Chem Pharm Bull (Tokyo); 2003 Apr; 51(4):390-8. PubMed ID: 12672990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological evaluation of N-acyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
    Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S
    Bioorg Med Chem; 2004 Mar; 12(5):871-82. PubMed ID: 14980599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel potent anticonvulsant agent containing a tetrahydroisoquinoline skeleton.
    Gitto R; Caruso R; Pagano B; De Luca L; Citraro R; Russo E; De Sarro G; Chimirri A
    J Med Chem; 2006 Sep; 49(18):5618-22. PubMed ID: 16942035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and structure-activity relationships of novel selective factor Xa inhibitors with a tetrahydroisoquinoline ring.
    Ueno H; Yokota K; Hoshi J; Yasue K; Hayashi M; Hase Y; Uchida I; Aisaka K; Katoh S; Cho H
    J Med Chem; 2005 May; 48(10):3586-604. PubMed ID: 15887966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and pharmacological evaluation of piperidinoalkanoyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel specific bradycardic agents.
    Kubota H; Watanabe T; Kakefuda A; Masuda N; Wada K; Ishii N; Sakamoto S; Tsukamoto S
    Bioorg Med Chem Lett; 2004 Jun; 14(12):3049-52. PubMed ID: 15149642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (+/-)-2-(3-Piperidyl)-1,2,3,4-tetrahydroisoquinolines as a new class of specific bradycardic agents.
    Kubota H; Kakefuda A; Watanabe T; Taguchi Y; Ishii N; Masuda N; Sakamoto S; Tsukamoto Si
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2155-8. PubMed ID: 12798325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective estrogen receptor modulators with conformationally restricted side chains. Synthesis and structure-activity relationship of ERalpha-selective tetrahydroisoquinoline ligands.
    Renaud J; Bischoff SF; Buhl T; Floersheim P; Fournier B; Geiser M; Halleux C; Kallen J; Keller H; Ramage P
    J Med Chem; 2005 Jan; 48(2):364-79. PubMed ID: 15658851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and pharmacological evaluation of 1-isopropyl-1,2,3,4-tetrahydroisoquinoline derivatives as novel antihypertensive agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Chem Pharm Bull (Tokyo); 2011; 59(8):1029-37. PubMed ID: 21804249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent 4-aryl- or 4-arylalkyl-substituted 3-isoxazolol GABA(A) antagonists: synthesis, pharmacology, and molecular modeling.
    Frølund B; Jensen LS; Guandalini L; Canillo C; Vestergaard HT; Kristiansen U; Nielsen B; Stensbøl TB; Madsen C; Krogsgaard-Larsen P; Liljefors T
    J Med Chem; 2005 Jan; 48(2):427-39. PubMed ID: 15658856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and evaluation of analogues of 3,3,3-trifluoro-2-hydroxy-2-phenyl-propionamide as orally available general anesthetics.
    Choudhury-Mukherjee I; Schenck HA; Cechova S; Pajewski TN; Kapur J; Ellena J; Cafiso DS; Brown ML
    J Med Chem; 2003 Jun; 46(12):2494-501. PubMed ID: 12773053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular pharmacological characterization of novel 2,3-dimethyl-2-butylamine derivatives in rats.
    Chen YP; Qiu CR; Wang H
    Life Sci; 2004 Sep; 75(17):2131-42. PubMed ID: 15312756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and pharmacological evaluation of 1-alkyl-N-[2-ethyl-2-(4-fluorophenyl)butyl]piperidine-4-carboxamide derivatives as novel antihypertensive agents.
    Watanuki S; Matsuura K; Tomura Y; Okada M; Okazaki T; Ohta M; Tsukamoto S
    Bioorg Med Chem; 2011 Sep; 19(18):5628-38. PubMed ID: 21875808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of novel isoquinoline-3-nitriles as orally bioavailable Kv1.5 antagonists for the treatment of atrial fibrillation.
    Trotter BW; Nanda KK; Kett NR; Regan CP; Lynch JJ; Stump GL; Kiss L; Wang J; Spencer RH; Kane SA; White RB; Zhang R; Anderson KD; Liverton NJ; McIntyre CJ; Beshore DC; Hartman GD; Dinsmore CJ
    J Med Chem; 2006 Nov; 49(24):6954-7. PubMed ID: 17125248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and pharmacological properties of 6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives.
    Brzezińska E
    Acta Pol Pharm; 1996; 53(5):365-71. PubMed ID: 9415212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitors.
    Fang X; Yin Y; Chen YT; Yao L; Wang B; Cameron MD; Lin L; Khan S; Ruiz C; Schröter T; Grant W; Weiser A; Pocas J; Pachori A; Schürer S; Lograsso P; Feng Y
    J Med Chem; 2010 Aug; 53(15):5727-37. PubMed ID: 20684608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of a novel 4-aminomethyl-4-fluoropiperidine as a T-type Ca2+ channel antagonist.
    Shipe WD; Barrow JC; Yang ZQ; Lindsley CW; Yang FV; Schlegel KA; Shu Y; Rittle KE; Bock MG; Hartman GD; Tang C; Ballard JE; Kuo Y; Adarayan ED; Prueksaritanont T; Zrada MM; Uebele VN; Nuss CE; Connolly TM; Doran SM; Fox SV; Kraus RL; Marino MJ; Graufelds VK; Vargas HM; Bunting PB; Hasbun-Manning M; Evans RM; Koblan KS; Renger JJ
    J Med Chem; 2008 Jul; 51(13):3692-5. PubMed ID: 18540666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis and biological activity of substituted benzyl/naphthylmethylisoquinolines and related quaternary ammonium derivatives].
    Xu GY; Peng SX; Hua WY
    Yao Xue Xue Bao; 1994; 29(2):95-106. PubMed ID: 8042518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.
    Mohler ML; Kang GS; Hong SS; Patil R; Kirichenko OV; Li W; Rakov IM; Geisert EE; Miller DD
    J Med Chem; 2006 Sep; 49(19):5845-8. PubMed ID: 16970409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of pharmacological profile of 1-aryl-6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-sulfonamides.
    Gitto R; Ferro S; Agnello S; De Luca L; De Sarro G; Russo E; Vullo D; Supuran CT; Chimirri A
    Bioorg Med Chem; 2009 May; 17(10):3659-64. PubMed ID: 19398204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.